ABALLI JOHN 4
4 · EXAGEN INC. · Filed Oct 20, 2025
Insider Transaction Report
Form 4
EXAGEN INC.XGN
ABALLI JOHN
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-10-16$11.82/sh−31,787$375,598→ 714,427 total
Holdings
- 40,401(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.